gila monster and glp-1 Lessons from the Monster: Ketogenic Diets The Gila Monster Venom Lead

125 In vitro, DPP4 activity is selectively produced on the surface of senescent, but non-regenerating, human diploid fibroblasts and is greater in older individuals than in younger individuals

While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)

A review of 47 randomised controlled trials involving over 23,000 patients found that the greatest weight-loss effect from GLP-1 drugs was shown in participants who were young, female and not diagnosed with diabetes (so they therefore had better insulin sensitivity)

Rapid weight loss can temporarily increase uric acid levels in the bloodstream

Asthma RWE showed that individuals with obesity and asthma treated with GLP-1s experienced better symptom control and fewer exacerbations compared to non-users